Get startedLog in
    Picture of Lytix Biopharma AS logo

    LYTIX — Lytix Biopharma AS News Story

    0.000.00%
    no flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapMomentum Trap
    All News

    Brief: Lytix Biopharma Announces Interim Data On Neoadjuvant Treatment Of Melanoma

    Picture of Lytix Biopharma AS logoLytix Biopharma AS
    11/11/2025 06:13
    Nov 11 (Reuters) - Lytix Biopharma AS LYTIX.OL:

LYTIX BIOPHARMA ANNOUNCES PROMISING INTERIM DATA ON NEOADJUVANT TREATMENT OF MELANOMA WITH RUXOTEMITIDE FROM THE NEOLIPA STUDY AT THE NORWEGIAN RADIUM HOSPITAL

Source text: ID:nWkr1FPT2L

Further company coverage: LYTIX.OL

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on Lytix Biopharma AS

    See all news